Patients treated with Pt-based anticancer drugs (PtII) often experience severe side effects
and are susceptible to cancer recurrence due to the limited bioavailability of PtII and tumor …

Octahedral PtIV complexes are considered highly promising candidates for overcoming
some shortcomings of clinically approved PtII drugs. PtIV compounds, owing to their inertia …

Cancer remains a significant global health challenge, necessitating continuous
advancements in therapeutic strategies. Chemotherapeutic agents have long been pivotal in …

A planar conjugated ligand functionalized with bithiophene and its Ru (II), Os (II), and Ir (III)
complexes have been constructed as single‐molecule platform for synergistic …

Chemotherapy remains the primary treatment method for osteosarcoma after surgery.
However, the lack of selectivity of chemotherapy for osteosarcoma leads to unpredictable …

Mitophagy, a selective autophagic process, has emerged as a pathway involved in
degrading dysfunctional mitochondria. Herein, new platinum (II)-based chemotherapeutics …

The outcomes of DFT‐based calculations are here reported to assess the applicability of two
synthesized polypyridyl Ru (II) complexes, bearing ethynyl nile red (NR) on a bpy ligand …

For the first time, this study reported the photoactivatable activity of Ir (III)–Pt (IV)
heterometallic conjugates, which were stable in the dark and activated to release oxaliplatin …

A computational examination of two new polypyridyl ruthenium complexes, containing
meldola blue (MDB) and nile blue (NB) chromophores, is here reported in order to assess …

Flavin-like ligands (L-1 and L-2) with extended π-conjugation were synthesized using
microwave-assisted techniques. An N, N-chelating fragment was integrated into alloxazine …